6550--Blood Bank Reagents - New Base Plus Four Option Year Contract

The Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 5, is soliciting blood bank reagents for the Huntington VA Medical Center under a new base plus four option year contract, with quotation responses due August 17, 2026, at 10:00 a.m. EST. An amendment issued August 6 extended the original August 10 deadline and updated line items and RFQ language; responses must be emailed to Zachary Altner at Zachary.Altner@va.gov.

The procurement is unrestricted, set for full and open competition under NAICS 325413 (pharmaceutical preparation manufacturing, small business size standard 1,250 employees) and PSC 6550. Place of performance is 1540 Spring Valley Drive, Huntington, West Virginia 25704. The base period runs October 18, 2026, through October 17, 2027, with four optional years extending through October 17, 2031. The contract is firm fixed-price with FOB destination delivery.

Required supplies include five line items: 26 units of control blood bank confidence sera (2-level), 13 units of AB screening reagent (Surgiscreen 3%, 3-levels), 13 packages of reverse grouping reagent (A1 and B cells, 3%, 2-cells), 13 packages of RBC panel A reagent (3 mL liquid dropper bottle), and 26 units of Coombs control (10 mL dropper bottle, weak solution) and 13 units of A2 cells (1 × 10 mL package).

The contractor must be FDA-licensed or College of American Pathologists accredited, CLIA certified, and HIPAA compliant. Personnel requiring VA system access are subject to National Agency Check background investigations at contractor expense. The contractor must encrypt VA sensitive information using FIPS 140-2 validated tools and faces liquidated damages of $37.50 per affected individual for data breaches. Award is based on best value evaluation considering offered reagent characteristics, vendor past performance, and pricing. The contracting office is VA Maryland Health Care System, Perry Point, Maryland.